EPSILON ENERGY LTD (EPSN) Fundamental Analysis & Valuation

NASDAQ:EPSN • CA2943752097

Current stock price

5.805 USD
-0.03 (-0.43%)
Last:

This EPSN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. EPSN Profitability Analysis

1.1 Basic Checks

  • In the past year EPSN was profitable.
  • In the past year EPSN had a positive cash flow from operations.
  • Each year in the past 5 years EPSN has been profitable.
  • Each year in the past 5 years EPSN had a positive operating cash flow.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.66%, EPSN is in line with its industry, outperforming 59.90% of the companies in the same industry.
  • EPSN's Return On Equity of 5.87% is in line compared to the rest of the industry. EPSN outperforms 45.41% of its industry peers.
  • The Return On Invested Capital of EPSN (7.03%) is better than 65.70% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EPSN is significantly below the industry average of 22.49%.
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROIC 7.03%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • EPSN has a better Profit Margin (12.86%) than 63.28% of its industry peers.
  • In the last couple of years the Profit Margin of EPSN has declined.
  • EPSN has a better Operating Margin (29.19%) than 72.46% of its industry peers.
  • EPSN's Operating Margin has declined in the last couple of years.
  • EPSN has a Gross Margin of 74.48%. This is amongst the best in the industry. EPSN outperforms 85.99% of its industry peers.
  • In the last couple of years the Gross Margin of EPSN has remained more or less at the same level.
Industry RankSector Rank
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. EPSN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EPSN is still creating some value.
  • EPSN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for EPSN has been reduced compared to 5 years ago.
  • EPSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • EPSN has an Altman-Z score of 4.39. This indicates that EPSN is financially healthy and has little risk of bankruptcy at the moment.
  • EPSN has a Altman-Z score of 4.39. This is amongst the best in the industry. EPSN outperforms 87.44% of its industry peers.
  • There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.39
ROIC/WACC0.79
WACC8.87%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • EPSN has a Current Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
  • EPSN's Current ratio of 1.93 is fine compared to the rest of the industry. EPSN outperforms 74.40% of its industry peers.
  • EPSN has a Quick Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.93, EPSN is in the better half of the industry, outperforming 75.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EPSN Growth Analysis

3.1 Past

  • EPSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.00%, which is quite impressive.
  • The earnings per share for EPSN have been decreasing by -22.77% on average. This is quite bad
  • The Revenue has grown by 46.76% in the past year. This is a very strong growth!
  • Measured over the past years, EPSN shows a small growth in Revenue. The Revenue has been growing by 3.38% on average per year.
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

7

4. EPSN Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.85, the valuation of EPSN can be described as very reasonable.
  • EPSN's Price/Earnings ratio is a bit cheaper when compared to the industry. EPSN is cheaper than 79.71% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of EPSN to the average of the S&P500 Index (26.11), we can say EPSN is valued rather cheaply.
  • A Price/Forward Earnings ratio of 11.86 indicates a reasonable valuation of EPSN.
  • Based on the Price/Forward Earnings ratio, EPSN is valued cheaply inside the industry as 81.16% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, EPSN is valued rather cheaply.
Industry RankSector Rank
PE 11.85
Fwd PE 11.86
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EPSN is valued a bit cheaper than the industry average as 74.40% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, EPSN is valued a bit cheaper than the industry average as 63.28% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.52
EV/EBITDA 6.32
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. EPSN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.35%, EPSN is a good candidate for dividend investing.
  • EPSN's Dividend Yield is a higher than the industry average which is at 3.47.
  • EPSN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 4.35%

5.2 History

  • EPSN has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of EPSN decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 93.55% of the earnings are spent on dividend by EPSN. This is not a sustainable payout ratio.
DP93.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EPSN Fundamentals: All Metrics, Ratios and Statistics

EPSILON ENERGY LTD

NASDAQ:EPSN (3/18/2026, 1:43:44 PM)

5.805

-0.03 (-0.43%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05
Earnings (Next)03-24
Inst Owners51.47%
Inst Owner Change63.39%
Ins Owners7.14%
Ins Owner Change5.22%
Market Cap174.03M
Revenue(TTM)45.71M
Net Income(TTM)5.88M
Analysts82.86
Price Target8.57 (47.63%)
Short Float %3.4%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 4.35%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP93.55%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)163.48%
Min EPS beat(2)132.84%
Max EPS beat(2)194.12%
EPS beat(4)3
Avg EPS beat(4)77.96%
Min EPS beat(4)-41.18%
Max EPS beat(4)194.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.62%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-23.45%
Max Revenue beat(4)35.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.85
Fwd PE 11.86
P/S 3.81
P/FCF 17.52
P/OCF 6.72
P/B 1.74
P/tB 1.74
EV/EBITDA 6.32
EPS(TTM)0.49
EY8.44%
EPS(NY)0.49
Fwd EY8.43%
FCF(TTM)0.33
FCFY5.71%
OCF(TTM)0.86
OCFY14.89%
SpS1.52
BVpS3.34
TBVpS3.34
PEG (NY)0.06
PEG (5Y)N/A
Graham Number6.07
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROCE 11.46%
ROIC 7.03%
ROICexc 7.9%
ROICexgc 7.9%
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
FCFM 21.73%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexgc growth 3Y-47.2%
ROICexgc growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.79%
Cap/Sales 34.94%
Interest Coverage 1347.55
Cash Conversion 101.01%
Profit Quality 168.97%
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 4.39
F-Score7
WACC8.87%
ROIC/WACC0.79
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.55%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.88%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%

EPSILON ENERGY LTD / EPSN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EPSN.


What is the valuation status for EPSN stock?

ChartMill assigns a valuation rating of 7 / 10 to EPSILON ENERGY LTD (EPSN). This can be considered as Undervalued.


How profitable is EPSILON ENERGY LTD (EPSN) stock?

EPSILON ENERGY LTD (EPSN) has a profitability rating of 5 / 10.


How financially healthy is EPSILON ENERGY LTD?

The financial health rating of EPSILON ENERGY LTD (EPSN) is 8 / 10.


What is the earnings growth outlook for EPSILON ENERGY LTD?

The Earnings per Share (EPS) of EPSILON ENERGY LTD (EPSN) is expected to grow by 206% in the next year.